Primary Cutaneous Posttransplant Lymphoproliferative Disorders in Solid Organ Tranpsplant Recipients: A Multicenter European Case Series

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F13%3A10134351" target="_blank" >RIV/00216208:11140/13:10134351 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00669806:_____/13:10134351

Výsledek na webu

<a href="http://onlinelibrary.wiley.com/doi/10.1111/ajt.12281/pdf" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/ajt.12281/pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/ajt.12281" target="_blank" >10.1111/ajt.12281</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Primary Cutaneous Posttransplant Lymphoproliferative Disorders in Solid Organ Tranpsplant Recipients: A Multicenter European Case Series

Popis výsledku v původním jazyce

Primary cutaneous posttransplant lymphoproliferative disorders (PTLD) are rare. This retrospective, multicenter study of 35 cases aimed to better describe this entity. Cases were (re)-classified according to the WHO-EORTC or the WHO 2008 classificationsof lymphomas. Median interval between first transplantation and diagnosis was 85 months. Fifty-seven percent of patients had a kidney transplant. Twenty-four cases (68,6%) were classified as primary cutaneous T cell lymphoma (CTCL) and 11 (31,4%) as primary cutaneous B cell PTLD. Mycosis fungoides (MF) was the most common (50%) CTCL subtype. Ten (90,9%) cutaneous B cell PTLD cases were classified as EBV-associated B cell lymphoproliferations (including one plasmablastic lymphoma and one lymphomatoid granulomatosis) and one as diffuse large B cell lymphoma, other, that was EBV-negative. Sixteen (45,7%) patients died after a median follow-up of 19.5 months (11 [68,8%] with CTCL [6 of whom had CD30+ lymphoproliferative disorders (LPD)] and

Název v anglickém jazyce

Primary Cutaneous Posttransplant Lymphoproliferative Disorders in Solid Organ Tranpsplant Recipients: A Multicenter European Case Series

Popis výsledku anglicky

Primary cutaneous posttransplant lymphoproliferative disorders (PTLD) are rare. This retrospective, multicenter study of 35 cases aimed to better describe this entity. Cases were (re)-classified according to the WHO-EORTC or the WHO 2008 classificationsof lymphomas. Median interval between first transplantation and diagnosis was 85 months. Fifty-seven percent of patients had a kidney transplant. Twenty-four cases (68,6%) were classified as primary cutaneous T cell lymphoma (CTCL) and 11 (31,4%) as primary cutaneous B cell PTLD. Mycosis fungoides (MF) was the most common (50%) CTCL subtype. Ten (90,9%) cutaneous B cell PTLD cases were classified as EBV-associated B cell lymphoproliferations (including one plasmablastic lymphoma and one lymphomatoid granulomatosis) and one as diffuse large B cell lymphoma, other, that was EBV-negative. Sixteen (45,7%) patients died after a median follow-up of 19.5 months (11 [68,8%] with CTCL [6 of whom had CD30+ lymphoproliferative disorders (LPD)] and

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FO - Dermatovenerologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

American Journal of Transplantation

ISSN

1600-6135

e-ISSN

—

Svazek periodika

13

Číslo periodika v rámci svazku

8

Stát vydavatele periodika

DK - Dánské království

Počet stran výsledku

8

Strana od-do

2146-2153

Kód UT WoS článku

000322330000026

EID výsledku v databázi Scopus

—